SWH - Verulam Chronic Migraine Service 25/27

Description

The chronic migraine service is provided by Neecare Health Care Ltd<br/>The service undertakes clinical management of chronic migraine for patients who suffer persistent headache.<br/><br/>Neecare chronic migraine service provides clinical intervention for the management of chronic migraine by administering Botulinum injection including regular therapy.<br/><br/>Patients are referred by Neurologist having been diagnosed with Chronic Migraine and meet NICE Guidelines for Botulinum Injection administration.<br/><br/>To confirm, as per the PSR direct award process C, the existing provider is satisfying the existing contract, delivering a good service, meeting all KPIs, with no quality concerns with very good feedback from Clinicians and patients and are likely to satisfy the new contract, The proposed contracting arrangements are not changing from the existing contract. Lot 1: The Chronic Migraine Clinic provide treatment for patients who suffer from persistence headache of:<br/>• Either tension-type and/or migraine quality and occurs on ≥15 days per month for at least 3 months.<br/>• No medication overuse.<br/><br/>A strict referral criterion ensures patients would have to see a Neurologist to be diagnosed with Chronic Migraine and then meets the NICE Guidelines for Botulinum administration.<br/>As such the clinic only accepts referrals from a Neurologist who has diagnosed Chronic Migraine in the patient and who fulfil the NICE criteria. <br/><br/>The clinic maintains close links with the Neurology department at East & North Hertfordshire Trust to receive appropriate support, resources, and education. <br/> <br/>The clinic offers face to face and virtual educational sessions about chronic migraine with clearly defined pathway. <br/><br/>The contract is for one year with option to renew for a further one year based on FOT of £77, 748. Additional information: The contract is for one year with option to renew for a further one year based on FOT of £77, 748. From April 2025 to March 2027